Axxcess Wealth Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,265	Closed	-$234K	–	858
2024 Q4	$234K	Sell	1,265 -18	-1%	-$3.47K	0.01%	757
2024 Q3	$253K	Sell	1,283 -41	-3%	-$8.52K	0.01%	749
2024 Q2	$274K	Sell	1,324 -770	-37%	-$174K	0.01%	687
2024 Q1	$567K	Buy	2,094 +741	+55%	+$177K	0.02%	508
2023 Q4	$320K	Sell	1,353 -10	-0.7%	-$1.97K	0.01%	628
2023 Q3	$267K	Buy	1,363 +141	+12%	+$28.9K	0.01%	629
2023 Q2	$257K	Sell	1,222 -61	-5%	-$12.1K	0.02%	489
2023 Q1	$259K	Sell	1,283 -1	-0.1%	-$227	0.02%	519
2022 Q4	$280K	Sell	1,284 -835	-39%	-$182K	0.02%	462
2022 Q3	$417K	Buy	2,119 +124	+6%	+$26.8K	0.04%	348
2022 Q2	$426K	Sell	1,995 -467	-19%	-$114K	0.04%	333
2022 Q1	$699K	Sell	2,462 -602	-20%	-$186K	0.05%	291
2021 Q4	$1.15M	Buy	+3,064	New	+$1.19M	0.08%	189